Burris, Scott <br/><br/>
Assessing social risks prior to commencement of a clinical trial: due diligence or ethical inflation?  [electronic resource] 

 -  The American journal of bioethics : AJOB  Nov 2009 
 - 48-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1536-0075 
<br/><br/><label>Standard No.: </label>10.1080/15265160903197507  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Buprenorphine--therapeutic use<br/>Buprenorphine, Naloxone Drug Combination<br/>China<br/>Confidentiality--ethics<br/>Conflict of Interest<br/>Counseling<br/>Ethics Committees, Research--ethics<br/>Ethics, Research<br/>Female<br/>Financing, Government<br/>HIV Infections--etiology<br/>Health Services Accessibility--ethics<br/>Human Rights<br/>Humans<br/>Informed Consent--ethics<br/>International Cooperation<br/>Male<br/>Middle Aged<br/>Naloxone--therapeutic use<br/>Narcotic Antagonists--therapeutic use<br/>Opioid-Related Disorders--complications<br/>Patient Selection--ethics<br/>Randomized Controlled Trials as Topic--economics<br/>Research Design<br/>Research Subjects<br/>Risk Assessment<br/>Risk Reduction Behavior<br/>Social Environment<br/>Thailand<br/>United States<br/>Vulnerable Populations